Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Forst

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Current Diabetes Reviews|June 15, 2016
Pharmacological Intervention in Type 2 Diabetes Mellitus - A Pathophysiologically Reasoned Approach?Thomas Forst, Tim Heise, Leona Plum-Morschel
Expert Review of Cardiovascular Therapy|August 22, 2006
Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effectsAndreas Pfützner, Christian A Schneider, Thomas Forst
Journal of Diabetes Science and Technology|June 2, 2010
High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneAndreas Pfützner, Thomas Schöndorf, Markolf Hanefeld, et al.
Expert Opinion on Drug Delivery|June 13, 2014
Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionalsAndreas Pfützner, Thomas Forst, Marcus Niemeyer, et al.
Clinical Laboratory|August 3, 2004
Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid)Andreas Pfützner, Mirjam Löbig, Antonio Fortunato, et al.
Diabetes Technology & Therapeutics|June 17, 2004
Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitusAndreas Pfützner, Anke H Pfützner, Martin Larbig, et al.
Journal of Diabetes Science and Technology|October 10, 2017
Impact of Injection Speed, Volume, and Site on Pain SensationEric Zijlstra, Johannes Jahnke, Annelie Fischer, et al.
Diabetes Technology & Therapeutics|August 24, 2004
Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoringAndreas Pfützner, Andreas Caduff, Martin Larbig, et al.
Clinical Laboratory|December 4, 2003
Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistanceAndreas Pfützner, Matthias Langenfeld, Thomas Kunt, et al.
Diabetes/Metabolism Research and Reviews|October 24, 2020
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetesThomas Forst, Pratik Choudhary, Doron Schneider, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Current Diabetes Reviews|June 15, 2016
Pharmacological Intervention in Type 2 Diabetes Mellitus - A Pathophysiologically Reasoned Approach?Thomas Forst, Tim Heise, Leona Plum-Morschel
Expert Review of Cardiovascular Therapy|August 22, 2006
Pioglitazone: an antidiabetic drug with cardiovascular therapeutic effectsAndreas Pfützner, Christian A Schneider, Thomas Forst
Journal of Diabetes Science and Technology|June 2, 2010
High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazoneAndreas Pfützner, Thomas Schöndorf, Markolf Hanefeld, et al.
Expert Opinion on Drug Delivery|June 13, 2014
Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionalsAndreas Pfützner, Thomas Forst, Marcus Niemeyer, et al.
Clinical Laboratory|August 3, 2004
Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid)Andreas Pfützner, Mirjam Löbig, Antonio Fortunato, et al.
Diabetes Technology & Therapeutics|June 17, 2004
Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitusAndreas Pfützner, Anke H Pfützner, Martin Larbig, et al.
Journal of Diabetes Science and Technology|October 10, 2017
Impact of Injection Speed, Volume, and Site on Pain SensationEric Zijlstra, Johannes Jahnke, Annelie Fischer, et al.
Diabetes Technology & Therapeutics|August 24, 2004
Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoringAndreas Pfützner, Andreas Caduff, Martin Larbig, et al.
Clinical Laboratory|December 4, 2003
Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistanceAndreas Pfützner, Matthias Langenfeld, Thomas Kunt, et al.
Diabetes/Metabolism Research and Reviews|October 24, 2020
A practical approach to the clinical challenges in initiation of basal insulin therapy in people with type 2 diabetesThomas Forst, Pratik Choudhary, Doron Schneider, et al.
Pageof 15